<table cellpadding="0pt" cellspacing="0pt" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="43%"></col>
<col width="57%"></col>
<tfoot>
<tr>
<td align="left" colspan="2" stylecode="Botrule" valign="top">* The effect of phenytoin on phenobarbital, valproic acid and sodium valproate serum levels is unpredictable  </td>
</tr>
</tfoot>
<tbody>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Interacting Agent</content>
<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule Toprule " valign="middle">
<paragraph>
<content stylecode="bold">Examples</content>
<br/>
</paragraph>
</td>
</tr>
<tr>
<td colspan="2" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="bold">Drugs whose efficacy is impaired by phenytoin</content>
<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Azoles<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Fluconazole, ketoconazole, itraconazole, posaconazole, voriconazole<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Antineoplastic agents<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Irinotecan, paclitaxel, teniposide<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Delavirdine<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Phenytoin can substantially reduce the concentrations of delavirdine. This can lead to loss of virologic response and possible resistance <content stylecode="italics">[see <linkhtml href="#Section_4">Contraindications (4)</linkhtml>].</content>
<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Neuromuscular blocking agents<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Cisatracurium, pancuronium, rocuronium and vecuronium: resistance to the neuromuscular blocking action of the nondepolarizing neuromuscular blocking agents has occurred in patients chronically administered phenytoin. Whether or not phenytoin has the same effect on other non-depolarizing agents is unknown.<br/>
<content stylecode="italics">
<content stylecode="underline">Prevention or Management:</content>
</content>  Patients should be monitored closely for more rapid recovery from neuromuscular blockade than expected, and infusion rate requirements may be higher.<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Warfarin<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Increased and decreased PT/INR responses have been reported when phenytoin is coadministered with warfarin<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Other<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Corticosteroids, doxycycline, estrogens, furosemide, oral contraceptives, paroxetine, quinidine, rifampin, sertraline, theophylline, and vitamin D<br/>
</paragraph>
</td>
</tr>
<tr>
<td colspan="2" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>
<content stylecode="bold">Drugs whose level is decreased by phenytoin</content>
<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Antiepileptic drugs*<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Carbamazepine, felbamate, lamotrigine, topiramate, oxcarbazepine,<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>Antilipidemic agents<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="middle">
<paragraph>Atorvastatin, fluvastatin, simvastatin<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Antiviral agents<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Efavirenz, lopinavir/ritonavir, indinavir, nelfinavir, ritonavir, saquinavir Fosamprenavir: phenytoin when given with fosamprenavir alone may decrease the concentration of amprenavir, the active metabolite. Phenytoin when given with the combination of fosamprenavir and ritonavir may increase the concentration of amprenavir<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>Calcium channel blockers<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="middle">
<paragraph>Nifedipine, nimodipine, nisoldipine, verapamil<br/>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>Other<br/>
</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Albendazole (decreases active metabolite), chlorpropamide, clozapine, cyclosporine, digoxin, folic acid, methadone, mexiletine, praziquantel, quetiapine<br/>
</paragraph>
</td>
</tr>
</tbody>
</table>